
Burford Capital Limited BUR
$ 3.24
-6.36%
Burford Capital Limited Current Ratio | BUR
Annual Current Ratio Burford Capital Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.89 | 2.12 | 2.22 | 2.26 | 2.29 | 2.14 | 1.98 | 2.43 | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.43 | 1.89 | 2.16 |
Quarterly Current Ratio Burford Capital Limited
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.56 | 1.52 | 1.55 | 1.89 | 1.91 | 2.04 | 2.05 | 2.12 | 2.22 | 2.26 | - | - | - | 2.29 | - | - | - | 2.63 | - | - | - | 1.98 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.63 | 1.52 | 2 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amgen
AMGN
|
1.44 | $ 435.4 | -0.21 % | $ 234 B | ||
|
RedHill Biopharma Ltd.
RDHL
|
0.794 | $ 0.29 | -11.35 % | $ 3.57 B | ||
|
Seagen
SGEN
|
6.69 | - | - | $ 42.2 B | ||
|
Baudax Bio
BXRX
|
0.293 | - | 0.59 % | $ 63 K | ||
|
ChemoCentryx
CCXI
|
3.05 | - | - | $ 3.74 B | ||
|
Avid Bioservices
CDMO
|
1.22 | - | - | $ 789 M | ||
|
Zosano Pharma Corporation
ZSAN
|
3.14 | - | 7.23 % | $ 2.72 M | ||
|
Spectrum Pharmaceuticals
SPPI
|
1.37 | - | - | $ 189 M | ||
|
Alpine Immune Sciences
ALPN
|
7.32 | - | - | $ 2.17 B | ||
|
Berkeley Lights
BLI
|
2.69 | - | -7.31 % | $ 87 M | ||
|
Kaleido Biosciences
KLDO
|
1.27 | - | -3.69 % | $ 12.4 M | ||
|
VBI Vaccines
VBIV
|
5.56 | - | -50.87 % | $ 1.09 M | ||
|
CTI BioPharma Corp.
CTIC
|
0.878 | - | - | $ 1.2 B | ||
|
Decibel Therapeutics
DBTX
|
2.97 | - | - | $ 123 M | ||
|
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 26.35 | -3.02 % | $ 3.35 B | ||
|
IVERIC bio
ISEE
|
5.05 | - | - | $ 5.51 B | ||
|
ObsEva SA
OBSV
|
1.7 | - | -15.52 % | $ 10.5 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
2.73 | $ 41.53 | -4.86 % | $ 5.88 B | ||
|
Monopar Therapeutics
MNPR
|
48.7 | $ 69.02 | -1.81 % | $ 512 M | ||
|
Poseida Therapeutics
PSTX
|
1.61 | - | - | $ 857 M | ||
|
Y-mAbs Therapeutics
YMAB
|
4.3 | - | - | $ 382 M | ||
|
Satsuma Pharmaceuticals
STSA
|
6.77 | - | -0.9 % | $ 36.5 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
11.6 | $ 0.59 | -11.3 % | $ 50.3 M | ||
|
SpringWorks Therapeutics
SWTX
|
5.53 | - | - | $ 3.48 B | ||
|
Axon Enterprise
AXON
|
1.86 | $ 291.02 | -5.2 % | $ 22.7 B | ||
|
Infinity Pharmaceuticals
INFI
|
0.689 | - | -46.98 % | $ 3.57 M | ||
|
Ayala Pharmaceuticals
AYLA
|
6.17 | - | - | $ 7.46 M | ||
|
Evelo Biosciences
EVLO
|
0.928 | - | -14.46 % | $ 27.9 M | ||
|
Morphic Holding
MORF
|
28.3 | - | - | $ 2.42 B | ||
|
Genocea Biosciences
GNCA
|
1.94 | - | -15.0 % | $ 3.04 M | ||
|
Biogen
BIIB
|
2.63 | $ 249.55 | 0.98 % | $ 36.6 B | ||
|
Bristol-Myers Squibb Company
BMY
|
1.26 | $ 58.74 | 0.69 % | $ 119 B | ||
|
Eiger BioPharmaceuticals
EIGR
|
0.729 | - | -9.21 % | $ 2.55 M | ||
|
IGM Biosciences
IGMS
|
1.22 | - | - | $ 76.9 M | ||
|
Merrimack Pharmaceuticals
MACK
|
43.5 | - | - | $ 216 M | ||
|
Rubius Therapeutics
RUBY
|
2.91 | - | -33.55 % | $ 7.81 M | ||
|
Mirati Therapeutics
MRTX
|
5.83 | - | - | $ 3.3 B | ||
|
InVivo Therapeutics Holdings Corp.
NVIV
|
6.12 | - | -37.48 % | $ 476 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.32 | - | -9.72 % | $ 5.89 M | ||
|
Orchard Therapeutics plc
ORTX
|
1.81 | - | 1.02 % | $ 90.8 M | ||
|
La Jolla Pharmaceutical Company
LJPC
|
0.603 | - | - | $ 154 M | ||
|
Oyster Point Pharma
OYST
|
1.81 | - | - | $ 300 M | ||
|
Intercept Pharmaceuticals
ICPT
|
1.2 | - | - | $ 643 M | ||
|
Chinook Therapeutics
KDNY
|
4.34 | - | - | $ 2.6 B | ||
|
Syros Pharmaceuticals
SYRS
|
2.12 | - | -8.44 % | $ 3.4 M | ||
|
NanoViricides
NNVC
|
8.23 | $ 1.15 | -2.54 % | $ 23.2 M | ||
|
GT Biopharma
GTBP
|
6.14 | $ 2.93 | -7.86 % | $ 16.2 M | ||
|
Zymeworks
ZYME
|
2.78 | $ 26.41 | -1.68 % | $ 1.36 B | ||
|
Aldeyra Therapeutics
ALDX
|
2.59 | $ 0.84 | 16.41 % | $ 50.4 M | ||
|
Citius Pharmaceuticals
CTXR
|
2.45 | $ 0.51 | 1.61 % | $ 5.64 M |